Genetic engineering of influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine

Authors

• anya Dogra, Max Planck Institute for Dynamics of Complex Technical Systems, GermanyFollow
• Lars Pelz, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering
• Daniel Ruediger, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering
• Julia Boehme, Otto von Guericke University Magdeburg, Institute of Medical Microbiology
• Maike Baelkner, Helmholtz Centre for Infection Research, Immune Regulation
• Olivia Kershaw, Freie Universitaet Berlin, Department of Veterinary Pathology
• Yvonne Genzel, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering
• Dunja Bruder, Helmholtz Centre for Infection Research, Immune Regulation
• Sascha Kupke, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering
• Udo Reichl, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

anya Dogra, Lars Pelz, Daniel Ruediger, Julia Boehme, Maike Baelkner, Olivia Kershaw, Yvonne Genzel, Dunja Bruder, Sascha Kupke, and Udo Reichl, "Genetic engineering of influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/95